ATP6AP1 and colorectal carcinoma: Kaplan–Meier analysis of two independent cohorts indicated that CRC patients with higher amounts of ATP6AP1 presented shorter OS times (p = 0.031; HR = 2.99) (Fig. 7G), and the higher age showed worse prognosis (p = 0.037; HR = 2.88) (Fig. 7H).